Ontology highlight
ABSTRACT:
SUBMITTER: Ma C
PROVIDER: S-EPMC6600510 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature
Molecules (Basel, Switzerland) 20190611 11
Pasireotide is a multi-receptor ligand somatostatin analogue approved for medical treatment of Cushing's disease and acromegaly. The liquid-phase total synthesis of pasireotide-a 18-membered cyclic hexapeptide-was achieved by the 3 + 2 + 1 strategy, and the Pro<sup>1</sup>-Phe<sup>6</sup> peptide bond was selected as the final cyclization position. Two key fragments were simply synthesized using <i>N</i>,<i>O</i>-bis(trimethylsilyl)acetamide/<i>N</i>-hydroxysuccinimide ester (BSA/NHS) as couplin ...[more]